teladoc glp-1 ๐ For the past few years, receptor agonists have dominated the conversation around weight management. This month, the MHRA approved the UK's first oral GLP-1 receptor agonist tablet forโฆ Say Hello To The Largest
Description
Maybe not so much anymore
Between 89% and 91% of participants on the 10 mg or 15 mg doses achieved at least 5% weight loss
Together, these four principles shift the clinical conversation from a question of which therapy to use toward a more sophisticated question of how to combine them most effectively, for which patient, at which stage of the transition, and toward which specific physiological objectives
Muller DRP, Stenvers DJ, Malekzadeh A, Holleman F, Painter RC, Siegelaar SE
Discuss full history with a provider
